Full-Time

Head of GI a&I

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$208.2k - $327.1k/yr

+ Short-term Incentives + Long-term Incentives

Senior, Expert

Boston, MA, USA

This position is currently classified as 'hybrid' in accordance with Takeda's Hybrid and Remote Work policy. Occasional domestic overnight travel may be required.

Category
Management Consulting
Consulting
Required Skills
Market Research
Business Analytics
Data Analysis
Requirements
  • Bachelor’s degree in mathematics, engineering, business, marketing analytics or a related field required with a master’s degree in business, science, engineering or advanced analytics preferred
  • 10+ years’ experience in Insights & Analytics role or related positions with in-depth experience of innovating and implementing successful market research and analytics capabilities required
  • 5+ years of progressive people and project management; experience as a leader of leaders, a plus
  • Ability to provide full oversight to the full spectrum of pharmaceutical analytical functions and the ability to conduct business analytics and market research across multiple therapeutic areas
  • Deep expertise in pharmaceutical data sources and their application to support business decisions. Experience utilizing limited/ sub-optimal data to gain insights in specialty pharmaceutical products or orphan/ rare diseases. Ability to combine primary data sources and secondary market research insights to support sales and marketing strategies and forecasting
  • Comprehension of early commercial strategy and U.S. launch expertise, sales force execution and insight gathering methodologies needed to evolve pre-launch strategy. Launch experience from I&A capabilities perspective is critical
  • Deep expertise in primary market research methods, data coverage and strategy and analytics tools including appropriate patient cohort analysis and new ways to strategically leverage data and effectively utilize advanced analytics COE
  • Manages budget to support GI Primary Market Research and Analytics, along with identify risks and ops for the BU and franchise P&L
  • Leads a team of about 4 people leaders leading GI franchises
  • Actively hires, develops, and mentors talent creating a learning organization
  • Builds and maintains a learning and continuous-development environment to ensure employee engagement and growth, while identifying and rectifying poor performance
  • Motivates teams to excel by leveraging personal strengths and coaching, helping to leverage areas of strength and improving in areas for development
  • Travel Requirement-Occasional domestic overnight travel may be required
Responsibilities
  • Sets strategic direction, driving analytics and leading insights generation and value proposition development for the GI Business Insights team
  • Leads, manages and continues to evolve the development of a holistic cross-functional point of view to address ad hoc cross-brand and/or cross-functional business questions that require the integration of input from marketing, sales, market access, and patient services analytics, decision science, and primary market research. Creates value by adding own and synthesizing groups’ insights into actionable outputs with insights from the results, elevating the 'why' of the visual information
  • Partners with franchise leads to identify strategic priorities for the in-line and launch portfolio and craft analytics and insights plans to best meet the needs of the business. Communicates clear findings and recommends appropriate action to executive-level Franchise leadership
  • Identify, assess, and advance insights into the key internal and external factors that affect products in the BU landscape, including but not limited to: patient journey, assessment of a wide range of data sets to inform trends and opportunities, assessments to evaluate tactical plans and priorities, etc
  • Leads annual Brand Planning Situation Analysis workshops along with providing strategic input into annual franchise brand planning processes for in-line and pipeline products. Provides strategic input into the annual Global Brand Planning process which is disseminated to the LOCs for tactical execution
  • Partner with forecasting COE to provide direction for demand forecast, risks and ops
  • Partner closely with Commercial Operations, HEOR, sales force effectiveness, patient services, and managed markets teams to provide expertise and insights
  • Oversee competitive intelligence activities, serving as lead partner to align findings and implications cross-functionally and globally to inform mid and long-range forecasting efforts and creation of shared data and analytics to better mine data and understand the drivers of customer behaviors
  • Provide strategic insights and analysis to ensure clear brand strategies that address unmet need along the patient journey that will provide strategic direction, identify key insights and analytics relevant to promotional excellence, allow tracking based upon driven insights, and direction for the forecasting group to develop robust forecasts for product and trade-offs with other products in the franchise
  • Ensure best practices in marketed products and launch excellence insights and analytics by serving as a thought leader, providing strategic consulting and market perspective to key business stakeholders on strategies and risks, including significant trends, competitive positioning and consumer decision making drivers based on thorough trends, segment and marketing analysis
Desired Qualifications
  • Master’s degree in business, science, engineering or advanced analytics preferred

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene is worth up to $770 million.
  • The company is expanding its market presence in emerging Asian economies.
  • Takeda's focus on personalized medicine aligns with industry trends.

What critics are saying

  • Antitrust litigation over Amitiza could harm Takeda's reputation and finances.
  • A data breach incident poses significant cybersecurity and legal risks.
  • The telehealth market's rapid changes may affect Takeda's investment in American Well.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations.
  • Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

ETF Daily News
May 11th, 2025
Tudor Investment Corp ET AL Decreases Stock Holdings in American Well Co. (NYSE:AMWL)

Takeda Pharmaceutical Co. Ltd. acquired a new stake in American Well in the fourth quarter worth about $564,000.

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.